{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:29:22Z","timestamp":1788348562564,"version":"build-2803163510"},"reference-count":271,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006832","name":"Hunter College Center for HIV\/AIDS Educational Studies and Training","doi-asserted-by":"publisher","award":["T32 GM139776"],"award-info":[{"award-number":["T32 GM139776"]}],"id":[{"id":"10.13039\/100006832","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016618","name":"Gilbert Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015515","name":"Roy J. and Lucille A. Carver College of Medicine, University of Iowa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.preteyeres.2025.101359","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T19:14:47Z","timestamp":1745349287000},"page":"101359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genetics and current research models of Mendelian tumor predisposition syndromes with ocular involvement"],"prefix":"10.1016","volume":"106","author":[{"given":"Lola P.","family":"Lozano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Jennisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra G.","family":"Pandala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Culver","family":"Boldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budd A.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0464-3372","authenticated-orcid":false,"given":"Elaine M.","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2025.101359_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jpeds.2015.04.076","article-title":"Racial\/ethnic differences in pediatric brain tumor diagnoses in patients with neurofibromatosis type 1","volume":"167","author":"Abadin","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.preteyeres.2025.101359_bib2","first-page":"851","article-title":"Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography","volume":"10","author":"Abdolrahimzadeh","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13229-020-0320-2","article-title":"Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex","volume":"11","author":"Afshar Saber","year":"2020","journal-title":"Mol. Autism"},{"key":"10.1016\/j.preteyeres.2025.101359_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.cell.2007.09.036","article-title":"Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice","volume":"131","author":"Ajioka","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2025.101359_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","article-title":"The biology of uveal melanoma","volume":"36","author":"Amaro","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.preteyeres.2025.101359_bib6","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1038\/s41467-022-30466-6","article-title":"Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1","volume":"13","author":"Anastasaki","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101359_bib7","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.3390\/app13106304","article-title":"Ophthalmic manifestation in neurofibromatosis type 2","volume":"13","author":"Armentano","year":"2023","journal-title":"Appl. Sci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2024.101155","article-title":"Tuberous sclerosis complex: diagnostic features, surveillance, and therapeutic strategies","volume":"51","author":"Arredondo","year":"2024","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/tvst.9.7.39","article-title":"Characterization of uveal melanoma cell lines and primary tumor samples in 3D culture","volume":"9","author":"Aughton","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib10","first-page":"8573","article-title":"Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity","volume":"63","author":"Bajenaru","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/342716","article-title":"Predictors of the risk of mortality in neurofibromatosis 2","volume":"71","author":"Baser","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bjc.6605226","article-title":"Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma","volume":"101","author":"Bauer","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/bjc.2017.10","article-title":"A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1\/2 inhibitor","volume":"116","author":"Bendell","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/jmedgenet-2016-104058","article-title":"Survival and causes of death in patients with von Hippel-Lindau disease","volume":"54","author":"Binderup","year":"2017","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib15","series-title":"Clinical Ophthalmic Oncology: Retinal Tumors","first-page":"122","article-title":"Von hippel-lindau disease","author":"Binkley","year":"2019"},{"key":"10.1016\/j.preteyeres.2025.101359_bib16","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ajo.2005.12.042","article-title":"Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2","volume":"141","author":"Bosch","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1101\/gad.8.9.1019","article-title":"Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues","volume":"8","author":"Brannan","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.preteyeres.2025.101359_bib18","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1038\/s41467-018-07452-y","article-title":"NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation","volume":"9","author":"Brosseau","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101359_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainresbull.2011.08.005","article-title":"Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system","volume":"88","author":"Brossier","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.preteyeres.2025.101359_bib20","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1523\/JNEUROSCI.3994-09.2010","article-title":"Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity","volume":"30","author":"Brown","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib21","doi-asserted-by":"crossref","first-page":"16286","DOI":"10.1074\/jbc.M110.108167","article-title":"Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding","volume":"285","author":"Burke","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2025.101359_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12964-023-01223-z","article-title":"Retinoblastoma: present scenario and future challenges","volume":"21","author":"Byroju","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.preteyeres.2025.101359_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","article-title":"Advances in the clinical management of uveal melanoma","volume":"20","author":"Carvajal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2025.101359_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archopht.117.5.625","article-title":"VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma","volume":"117","author":"Chan","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib26","first-page":"75","article-title":"Von Hippel-Lindau gene deletion and expression of hypoxia-inducible factor and ubiquitin in optic nerve hemangioma","volume":"102","author":"Chan","year":"2004","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2025.101359_bib27","first-page":"697","article-title":"Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease","volume":"11","author":"Chan","year":"2005","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2025.101359_bib28","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1097\/01.mlg.0000240185.14224.7d","article-title":"Growth of benign and malignant schwannoma xenografts in severe combined immunodeficiency mice","volume":"116","author":"Chang","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.preteyeres.2025.101359_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/00016489409126077","article-title":"Subcutaneous growth of human acoustic schwannomas in athymic nude mice","volume":"114","author":"Charabi","year":"1994","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb1703","article-title":"Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin","volume":"7","author":"Cheah","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2025.101359_bib31","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1038\/onc.2013.418","article-title":"Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations","volume":"33","author":"Chen","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.preteyeres.2025.101359_bib32","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1158\/0008-5472.CAN-15-0370","article-title":"Paracrine effect of NRG1 and HGF drives resistance to MEK inhibitors in metastatic uveal melanoma","volume":"75","author":"Cheng","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clindermatol.2023.10.009","article-title":"Iris melanoma: review of clinical features, risks, management, and outcomes","volume":"42","author":"Cherkas","year":"2024","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/1545968310395601","article-title":"Nerve growth factor eye drop administration improves visual function in a patient with optic glioma","volume":"25","author":"Chiaretti","year":"2011","journal-title":"Neurorehabilitation Neural Repair"},{"key":"10.1016\/j.preteyeres.2025.101359_bib35","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1101\/gad.11.21.2822","article-title":"Cooperative effects of INK4a and ras in melanoma susceptibility in vivo","volume":"11","author":"Chin","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.preteyeres.2025.101359_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-444-62702-5.00010-X","article-title":"Von hippel-lindau disease","volume":"132","author":"Chittiboina","year":"2015","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1242\/dev.125.4.725","article-title":"A common precursor for hematopoietic and endothelial cells","volume":"125","author":"Choi","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.preteyeres.2025.101359_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000535427","article-title":"MEK inhibitor-associated ocular hypertension","volume":"10","author":"Collet","year":"2024","journal-title":"Ocul. Oncol. Pathol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.62.6.18","article-title":"Dissecting the transcriptional and chromatin accessibility heterogeneity of proliferating cone precursors in human retinoblastoma tumors by single cell sequencing\u2014opening pathways to new therapeutic strategies?","volume":"62","author":"Collin","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib40","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/humu.24465","article-title":"Long-read sequencing for molecular diagnostics in constitutional genetic disorders","volume":"43","author":"Conlin","year":"2022","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2025.101359_bib41","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.febslet.2014.04.001","article-title":"Molecular insights into NF2\/Merlin tumor suppressor function","volume":"588","author":"Cooper","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.preteyeres.2025.101359_bib43","series-title":"Clinical Ophthalmic Oncology: Uveal Tumors","first-page":"121","article-title":"Uveal melanoma: molecular pathology","author":"Coupland","year":"2019"},{"key":"10.1016\/j.preteyeres.2025.101359_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.spen.2015.10.002","article-title":"Genotype\/phenotype correlations in tuberous sclerosis complex","volume":"22","author":"Curatolo","year":"2015","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2023.101086","article-title":"Updated genotype-phenotype correlations in TSC","volume":"47","author":"Curatolo","year":"2023","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib46","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/hmg\/ddm059","article-title":"Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth","volume":"16","author":"Daginakatte","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib47","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1158\/0008-5472.CAN-08-2506","article-title":"Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation","volume":"68","author":"Daginakatte","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib48","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/NEN.0b013e31822200aa","article-title":"Comparative characterization of the human and mouse third ventricle germinal zones","volume":"70","author":"Dahiya","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.2136","article-title":"Comprehensive characterization and building of National Registry of von Hippel-Lindau disease in Brazil","volume":"11","author":"Dallagnol","year":"2023","journal-title":"Mol. Genet. Genomic. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/bjophthalmol-2019-314021","article-title":"Retinal haemangioblastoma associated with peripheral non-perfusion: widefield fluorescein angiography analysis of 41 cases","volume":"104","author":"Dalvin","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib51","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1167\/iovs.17-22302","article-title":"Pharmacokinetics, tissue localization, toxicity, and treatment efficacy in the first small animal (rabbit) model of intra-arterial chemotherapy for retinoblastoma","volume":"59","author":"Daniels","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib52","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ophtha.2023.12.014","article-title":"Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease","volume":"131","author":"Daniels","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101359_bib53","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/ICB.0000000000000193","article-title":"Ischemic retinopathy in neurofibromatosis type 1","volume":"9","author":"Dansingani","year":"2015","journal-title":"Retin. Cases Brief Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.preteyeres.2025.101359_bib54","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/WNO.0000000000000550","article-title":"Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision","volume":"37","author":"de Blank","year":"2017","journal-title":"J. Neuro Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib55","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/374821","article-title":"Elevated risk for MPNST in NF1 microdeletion patients","volume":"72","author":"De Raedt","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib56","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamaophthalmol.2016.0903","article-title":"Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes","volume":"134","author":"Decatur","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.24093","article-title":"Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1","volume":"75","author":"Diggs-Andrews","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib58","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1148\/radiology.195.3.7754001","article-title":"Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain","volume":"195","author":"DiPaolo","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.preteyeres.2025.101359_bib59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1741-7007-4-14","article-title":"Compensation by tumor suppressor genes during retinal development in mice and humans","volume":"4","author":"Donovan","year":"2006","journal-title":"BMC Biol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000519143","article-title":"Structural abnormalities of the central retina in neurofibromatosis type 2","volume":"65","author":"Emmanouil","year":"2022","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib61","series-title":"GeneReviews","article-title":"NF2-Related schwannomatosis","author":"Evans","year":"1989"},{"key":"10.1016\/j.preteyeres.2025.101359_bib62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-4-16","article-title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review","volume":"4","author":"Evans","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.preteyeres.2025.101359_bib63","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1186\/s12885-018-5079-x","article-title":"Comparison of germline versus somatic BAP1 mutations for risk of metastasis in uveal melanoma","volume":"18","author":"Ewens","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib64","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1172\/JCI42002","article-title":"Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma","volume":"120","author":"Eyles","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.preteyeres.2025.101359_bib65","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/brain\/awv366","article-title":"Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial","volume":"139","author":"Falsini","year":"2016","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib66","article-title":"BAP1 deficient human and mouse uveal melanomas up-regulate a shared EMT pathway","volume":"2023","author":"Farag","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.preteyeres.2025.101359_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12031214","article-title":"Assessment of retinal pigment epithelium alterations and chorioretinal vascular network analyses in patients under treatment with BRAF\/MEK inhibitor for different malignancies: a pilot study","volume":"12","author":"Fasolino","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib68","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ccr.2014.04.016","article-title":"Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry","volume":"25","author":"Feng","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.preteyeres.2025.101359_bib69","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ana.24157","article-title":"Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma","volume":"75","author":"Fisher","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib70","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bcmd.2013.09.006","article-title":"Erythro-myeloid progenitors: \"definitive\" hematopoiesis in the conceptus prior to the emergence of hematopoietic stem cells","volume":"51","author":"Frame","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.preteyeres.2025.101359_bib71","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.ophtha.2017.05.038","article-title":"Clinical and morphologic characteristics of MEK inhibitor-associated retinopathy: differences from central serous chorioretinopathy","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101359_bib72","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.oret.2021.06.001","article-title":"Clinical and morphologic characteristics of extracellular signal-regulated kinase inhibitor-associated retinopathy","volume":"5","author":"Francis","year":"2021","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2025.101359_bib73","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jamaophthalmol.2021.3331","article-title":"Clinical and morphologic characteristics of fibroblast growth factor receptor inhibitor-associated retinopathy","volume":"139","author":"Francis","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib74","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jnr.24250","article-title":"Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1","volume":"97","author":"Freret","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100910","article-title":"Von Hippel-Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein","volume":"297","author":"Frost","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2025.101359_bib76","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1523\/JNEUROSCI.0855-06.2006","article-title":"Specification of optic nerve oligodendrocyte precursors by retinal ganglion cell axons","volume":"26","author":"Gao","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddu414","article-title":"A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation","volume":"24","author":"Gehlhausen","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib78","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1093\/emboj\/17.14.4029","article-title":"The SCL gene specifies haemangioblast development from early mesoderm","volume":"17","author":"Gering","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.preteyeres.2025.101359_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12935-023-02940-8","article-title":"The genetic landscape and possible therapeutics of neurofibromatosis type 2","volume":"23","author":"Ghalavand","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.preteyeres.2025.101359_bib80","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/08820538.2022.2078165","article-title":"Liquid biopsy in Retinoblastoma: a review","volume":"37","author":"Ghose","year":"2022","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib81","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1101\/gad.13.8.978","article-title":"Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein","volume":"13","author":"Giovannini","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.preteyeres.2025.101359_bib82","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","article-title":"Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2","volume":"14","author":"Giovannini","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.preteyeres.2025.101359_bib83","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1158\/0008-5472.CAN-05-3505","article-title":"Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell","volume":"66","author":"Gl\u00e4sker","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib84","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1073\/pnas.94.17.9102","article-title":"Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice","volume":"94","author":"Gnarra","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2025.101359_bib85","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.3928\/23258160-20191031-12","article-title":"Efficacy of retinal lesion screening in von hippel-lindau patients with widefield color fundus imaging versus widefield FA","volume":"50","author":"Golas","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2025.101359_bib86","first-page":"6","article-title":"Multipoint linkage analysis in neurofibromatosis type I: an international collaboration","volume":"44","author":"Goldgar","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib87","series-title":"Exploration of VHL-Related Retinal Hemangioblastomas","author":"Gorin","year":"2023"},{"key":"10.1016\/j.preteyeres.2025.101359_bib88","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2009.11.FOCUS09221","article-title":"Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications","volume":"28","author":"Gottfried","year":"2010","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.preteyeres.2025.101359_bib89","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13816810802206507","article-title":"Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2","volume":"29","author":"Grant","year":"2008","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib90","first-page":"653","article-title":"SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain","volume":"7","author":"Green","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.preteyeres.2025.101359_bib91","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1444-0938.2012.00720.x","article-title":"Evolution of a juxtapapillary von Hippel-Lindau tumour examined by optical coherence tomography","volume":"95","author":"Grigoropoulos","year":"2012","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.preteyeres.2025.101359_bib93","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/neuonc\/noz080","article-title":"Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia","volume":"21","author":"Guo","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib94","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaophthalmol.2015.1119","article-title":"Clinical characteristics of uveal melanoma in patients with germline BAP1 mutations","volume":"133","author":"Gupta","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib95","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.neo.7900249","article-title":"Mouse models of neurofibromatosis 1 and 2","volume":"4","author":"Gutmann","year":"2002","journal-title":"Neoplasia"},{"key":"10.1016\/j.preteyeres.2025.101359_bib96","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1073\/pnas.88.21.9658","article-title":"Identification of the neurofibromatosis type 1 gene product","volume":"88","author":"Gutmann","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2025.101359_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.preteyeres.2025.101359_bib98","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.semcdb.2005.03.006","article-title":"The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting","volume":"16","author":"Haase","year":"2005","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib99","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1073\/pnas.98.4.1583","article-title":"Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor","volume":"98","author":"Haase","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2025.101359_bib100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","article-title":"Genetic Severity Score predicts clinical phenotype in NF2","volume":"54","author":"Halliday","year":"2017","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib101","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1755-148X.2012.00979.x","article-title":"The genetics of uveal melanoma: an emerging framework for targeted therapy","volume":"25","author":"Harbour","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib102","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101359_bib103","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.stem.2007.07.008","article-title":"Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms","volume":"1","author":"Hegedus","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.preteyeres.2025.101359_bib104","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/TACG.S69210","article-title":"The genetics of uveal melanoma: current insights","volume":"9","author":"Helgadottir","year":"2016","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1542\/peds.2007-3364","article-title":"Health supervision for children with neurofibromatosis","volume":"121","author":"Hersh","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2025.101359_bib106","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1897-4287-3-4-171","article-title":"Von hippel-lindau disease","volume":"3","author":"Hes","year":"2005","journal-title":"Hered. Cancer Clin. Pract."},{"issue":"4","key":"10.1016\/j.preteyeres.2025.101359_bib107","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.oret.2023.10.009","article-title":"Globe salvage and vision preservation by neoadjuvant darovasertib and crizotinib in uveal melanoma","volume":"8","author":"Hiong","year":"2023","journal-title":"Ophthalmol. Retina."},{"key":"10.1016\/j.preteyeres.2025.101359_bib108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/ceo.12806","article-title":"Ophthalmic manifestations of tuberous sclerosis: a review","volume":"45","author":"Hodgson","year":"2017","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib109","first-page":"1021","article-title":"Heterozygous Rb-1 delta 20\/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance","volume":"9","author":"Hu","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.preteyeres.2025.101359_bib110","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1158\/0008-5472.CAN-14-3229","article-title":"Oncogenic G protein GNAQ induces uveal melanoma and intravasation in mice","volume":"75","author":"Huang","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/genes13020362","article-title":"The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis","volume":"13","author":"Hudler","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.preteyeres.2025.101359_bib112","first-page":"475","article-title":"Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2","volume":"20","author":"Hung","year":"2002","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib113","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3171\/2021.3.JNS204203","article-title":"Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement","volume":"136","author":"Huntoon","year":"2022","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.preteyeres.2025.101359_bib114","doi-asserted-by":"crossref","first-page":"11661","DOI":"10.1073\/pnas.95.20.11661","article-title":"pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation","volume":"95","author":"Iliopoulos","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2025.101359_bib115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s42003-018-0163-y","article-title":"Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1","volume":"1","author":"Isakson","year":"2018","journal-title":"Commun. Biol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib116","series-title":"Retinoblastoma, StatPearls","author":"Ishaq","year":"2024"},{"key":"10.1016\/j.preteyeres.2025.101359_bib117","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/j.1460-2075.1991.tb04878.x","article-title":"Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein\/ret fusion gene","volume":"10","author":"Iwamoto","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.preteyeres.2025.101359_bib118","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib119","first-page":"T5","article-title":"Uveal melanoma cell lines: where do they come from? (An American ophthalmological society thesis)","volume":"114","author":"Jager","year":"2016","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2025.101359_bib120","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/1097-0142(197611)38:5<2042::AID-CNCR2820380529>3.0.CO;2-O","article-title":"Angiomatosis retinae. An ultrastructural study and lipid analysis","volume":"38","author":"Jakobiec","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib121","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.preteyeres.2025.101359_bib122","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2021.05.039","article-title":"Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis","volume":"154","author":"Jim\u00e9nez","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib123","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.preteyeres.2025.101359_bib124","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/ICB.0000000000001452","article-title":"Successful treatment of von hippel-lindau (VHL) disease-associated retinal capillary hemangioblastoma (RCH) with belzutifan in a pediatric patient","volume":"18","author":"Jones","year":"2023","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2025.101359_bib125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature23283","article-title":"Stimulation of functional neuronal regeneration from M\u00fcller glia in adult mice","volume":"548","author":"Jorstad","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2025.101359_bib126","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib127","first-page":"91","article-title":"The von Hippel\u2013Lindau Tumor Suppressor Protein","volume":"2","author":"Kaelin","year":"2018","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib128","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162480","article-title":"Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer","volume":"132","author":"Kaelin","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.preteyeres.2025.101359_bib129","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1101\/gad.226302","article-title":"Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse","volume":"16","author":"Kalamarides","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.preteyeres.2025.101359_bib130","doi-asserted-by":"crossref","DOI":"10.4103\/0301-4738.154367","article-title":"Uveal melanoma: estimating prognosis","volume":"63","author":"Kaliki","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib131","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/bjc.2014.417","article-title":"Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing","volume":"111","author":"Kalirai","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib132","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/394730","article-title":"Rabbit model of retinoblastoma","volume":"2011","author":"Kang","year":"2011","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.preteyeres.2025.101359_bib133","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/neuonc\/nou329","article-title":"Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth","volume":"17","author":"Kaul","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib134","series-title":"Ryan's Retina","first-page":"2517","article-title":"Retinoblastoma","author":"Kim","year":"2023"},{"key":"10.1016\/j.preteyeres.2025.101359_bib135","article-title":"NF2-Related schwannomatosis (NF2): molecular insights and therapeutic avenues","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib136","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0387-7604(86)80096-1","article-title":"High incidence of fundus hamartomas and clinical significance of a fundus score in tuberous sclerosis","volume":"8","author":"Kiribuchi","year":"1986","journal-title":"Brain Dev."},{"key":"10.1016\/j.preteyeres.2025.101359_bib137","series-title":"Clinical Ophthalmic Oncology: Uveal Tumors","first-page":"109","article-title":"Uveal melanoma: histopathologic features","author":"Kivel\u00e4","year":"2019"},{"key":"10.1016\/j.preteyeres.2025.101359_bib138","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2025.101359_bib139","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","article-title":"Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844-848","volume":"102","author":"Koczkowska","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/bjc.2013.299","article-title":"Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11","volume":"109","author":"Koopmans","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib141","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/bjo.82.8.953","article-title":"Pigmented uveal tumours in a transgenic mouse model","volume":"82","author":"Kramer","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081758","article-title":"Uveal melanoma: comprehensive review of its pathophysiology, diagnosis, treatment, and future perspectives","volume":"12","author":"Kulbay","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.preteyeres.2025.101359_bib143","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.4103\/ijo.IJO_802_19","article-title":"Insights into retinal hemangioblastoma using ultra widefield imaging","volume":"67","author":"Kumar","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib144","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cncr.33978","article-title":"Management recommendations for pancreatic manifestations of von Hippel-Lindau disease","volume":"128","author":"Laks","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib145","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101359_bib146","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1038\/sj.onc.1210261","article-title":"Tumor microenvironment and neurofibromatosis type I: connecting the GAPs","volume":"26","author":"Le","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.preteyeres.2025.101359_bib147","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/bjo.2005.077701","article-title":"Retinal ischaemia in type 1 neurofibromatosis","volume":"90","author":"Lecleire-Collet","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib148","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00177613","article-title":"Growth of human acoustic neuromas, neurofibromas and schwannomas in the subrenal capsule and sciatic nerve of the nude mouse","volume":"14","author":"Lee","year":"1992","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib149","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib150","article-title":"Hamartin: an endogenous neuroprotective molecule induced by hypoxic preconditioning","volume":"11","author":"Li","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib151","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ophtha.2006.05.068","article-title":"Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease","volume":"114","author":"Liang","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101359_bib152","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","article-title":"Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study","volume":"125","author":"Listernick","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.preteyeres.2025.101359_bib153","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2022.104538","article-title":"von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance","volume":"65","author":"Louise M Binderup","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib155","article-title":"Detection of retinal microvascular changes in von Hippel-Lindau disease using optical coherence tomography angiography","volume":"15","author":"Lu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101359_bib156","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1012271206258","article-title":"Electro-oculogram in patients with neurofibromatosis type 1","volume":"103","author":"Lubi\u0144ski","year":"2001","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib157","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1897-4287-2-4-193","article-title":"Supernormal electro-oculograms in patients with neurofibromatosis type 1","volume":"2","author":"Lubi\u0144ski","year":"2004","journal-title":"Hered. Cancer Clin. Pract."},{"key":"10.1016\/j.preteyeres.2025.101359_bib158","first-page":"5320","article-title":"Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene","volume":"63","author":"Ma","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib159","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00240-4","article-title":"Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth","volume":"3","author":"Mack","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.preteyeres.2025.101359_bib160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","article-title":"von Hippel-Lindau disease","volume":"76","author":"Maher","year":"1997","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.preteyeres.2025.101359_bib161","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40142-019-00180-9","article-title":"von Hippel-Lindau Disease: an Update","volume":"7","author":"Maher","year":"2019","journal-title":"Curr. Genetic Med. Rep."},{"key":"10.1016\/j.preteyeres.2025.101359_bib162","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease","volume":"77","author":"Maher","year":"1990","journal-title":"Q. J. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib163","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","article-title":"Von Hippel-Lindau disease: a genetic study","volume":"28","author":"Maher","year":"1991","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib164","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/13816819509059966","article-title":"Clinical features and molecular genetics of Von Hippel-Lindau disease","volume":"16","author":"Maher","year":"1995","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib165","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/genes15030332","article-title":"The genetics of tuberous sclerosis complex and related mTORopathies: current understanding and future directions","volume":"15","author":"Man","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.preteyeres.2025.101359_bib166","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0888-7543(91)90017-9","article-title":"cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product","volume":"11","author":"Marchuk","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.preteyeres.2025.101359_bib167","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40246-023-00529-w","article-title":"Genetics in ophthalmology: molecular blueprints of retinoblastoma","volume":"17","author":"Markovi\u0107","year":"2023","journal-title":"Hum. Genom."},{"key":"10.1016\/j.preteyeres.2025.101359_bib168","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.joco.2018.02.005","article-title":"Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma","volume":"30","author":"Masoomian","year":"2018","journal-title":"J. Curr. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib169","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archopht.125.3.389","article-title":"Ocular pathologic findings of neurofibromatosis type 2","volume":"125","author":"McLaughlin","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib170","series-title":"VHL von Hippel-Lindau tumor suppressor [ Homo sapiens (human) ]","author":"Medicine","year":"2023"},{"key":"10.1016\/j.preteyeres.2025.101359_bib171","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1055\/s-0041-1725033","article-title":"Endolymphatic Sac Tumor Screening and Diagnosis in von Hippel-Lindau Disease: A Consensus Statement","volume":"83","author":"Mehta","year":"2022","journal-title":"J. Neurol. Surg. B Skull Base"},{"key":"10.1016\/j.preteyeres.2025.101359_bib172","series-title":"Clinical Ophthalmic Oncology: Retinoblastoma","first-page":"79","article-title":"Animal models in retinoblastoma research","author":"Mendel","year":"2019"},{"key":"10.1016\/j.preteyeres.2025.101359_bib173","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0896-6273(92)90279-M","article-title":"P0 promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice","volume":"8","author":"Messing","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.preteyeres.2025.101359_bib174","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1167\/iovs.10-5223","article-title":"Genotype-phenotype correlation in ocular von Hippel-Lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype","volume":"51","author":"Mettu","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib175","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2018.01.081","article-title":"GNA11 Q209L mouse model reveals RasGRP3 as an essential signaling node in uveal melanoma","volume":"22","author":"Moore","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.preteyeres.2025.101359_bib176","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/epi4.12286","article-title":"Epilepsy in tuberous sclerosis complex: findings from the TOSCA Study","volume":"4","author":"Nabbout","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.preteyeres.2025.101359_bib179","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall survival benefit with tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108767","article-title":"The isolated GTPase-activating-protein-related domain of neurofibromin-1 has a low conformational stability in solution","volume":"700","author":"Neira","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.preteyeres.2025.101359_bib181","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2015.65.6140","article-title":"Von hippel-lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome","volume":"34","author":"Nielsen","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib182","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101359_bib183","first-page":"521","article-title":"Genetic analysis of von Hippel-Lindau disease","volume":"31","author":"Nordstrom-O'Brien","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2025.101359_bib184","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1346-8138.1992.tb03799.x","article-title":"The neurofibromatosis type 1 (NF1) gene: identification and partial characterization of a putative tumor suppressor gene","volume":"19","author":"O'Connell","year":"1992","journal-title":"J. Dermatol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0896-6273(00)80939-3","article-title":"Focal ventricular origin and migration of oligodendrocyte precursors into the chick optic nerve","volume":"19","author":"Ono","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.preteyeres.2025.101359_bib186","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/WNO.0000000000000675","article-title":"Neurofibromatosis type 2-related eye disease correlated with genetic severity type","volume":"39","author":"Painter","year":"2019","journal-title":"J. Neuro Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib187","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gad.310797.117","article-title":"Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of Nf1 low-grade glioma growth","volume":"32","author":"Pan","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.preteyeres.2025.101359_bib188","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03580-6","article-title":"NF1 mutation drives neuronal activity-dependent initiation of optic glioma","volume":"594","author":"Pan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2025.101359_bib189","first-page":"1795","article-title":"Efficient hemangioma formation in virally-transduced VHL floxed mice is serotype-dependent, the association for research in vision and ophthalmology","volume":"64","author":"Parikh","year":"2023","journal-title":"Invest. Ophthalmol.; Visual Sci., New Orleans."},{"key":"10.1016\/j.preteyeres.2025.101359_bib190","first-page":"975","article-title":"Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma","volume":"27","author":"Park","year":"2012","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib191","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040060","article-title":"von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells","volume":"4","author":"Park","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib192","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.1320520411","article-title":"Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity","volume":"52","author":"Parry","year":"1994","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272741","article-title":"Dissecting the roles of the Tuberin protein in the subcellular localization of the G2\/M Cyclin, Cyclin B1","volume":"17","author":"Pillon","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101359_bib194","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082677","article-title":"Macular perfusion impairment in von hippel-lindau disease suggests a generalized retinal vessel alteration","volume":"9","author":"Pilotto","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41598-020-79652-w","article-title":"Structural and microvascular changes of the peripapillary retinal nerve fiber layer in Von Hippel-Lindau disease: an OCT and OCT angiography study","volume":"11","author":"Pilotto","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101359_bib196","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/1535-7163.MCT-19-0098","article-title":"Genomic profiling of metastatic uveal melanoma and clinical results of a phase I study of the protein kinase C inhibitor AEB071","volume":"19","author":"Piperno-Neumann","year":"2020","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.preteyeres.2025.101359_bib197","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41416-022-02133-6","article-title":"A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma","volume":"128","author":"Piperno-Neumann","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib198","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.23813","article-title":"Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation","volume":"73","author":"Pong","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib199","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10689-015-9855-3","article-title":"Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1","volume":"15","author":"Porcelli","year":"2016","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.preteyeres.2025.101359_bib200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.cgt.7701037","article-title":"Treatment of implantable NF2 schwannoma tumor models with oncolytic herpes simplex virus G47Delta","volume":"14","author":"Prabhakar","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.preteyeres.2025.101359_bib201","first-page":"765","article-title":"Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors","volume":"60","author":"Prowse","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cge.12630","article-title":"Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases","volume":"89","author":"Rai","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib203","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2350-11-4","article-title":"Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease","volume":"11","author":"Rasmussen","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib204","doi-asserted-by":"crossref","first-page":"8595","DOI":"10.1158\/0008-5472.CAN-04-1430","article-title":"In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations","volume":"64","author":"Rathmell","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib205","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/hmg\/4.11.2139","article-title":"Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene","volume":"4","author":"Richards","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib206","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/humu.22832","article-title":"High incidence of noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation","volume":"36","author":"Rojnueangnit","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2025.101359_bib207","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/stcltm\/szac008","article-title":"pRB-depleted pluripotent stem cell retinal organoids recapitulate cell state transitions of retinoblastoma development and suggest an important role for pRB in retinal cell differentiation","volume":"11","author":"Rozanska","year":"2022","journal-title":"Stem. Cells Transl. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib208","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ajo.2021.01.002","article-title":"Multimodal imaging in the diagnosis of exophytic juxtapapillary retinal capillary hemangioblastoma","volume":"225","author":"Russell","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib209","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s10072-023-06680-5","article-title":"Neurofibromatosis type 1 system-based manifestations and treatments: a review","volume":"44","author":"Saleh","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib210","series-title":"Clinical Ophthalmic Oncology: Retinal Tumors","first-page":"19","article-title":"Retinal capillary hemangioma","author":"Salvi","year":"2019"},{"key":"10.1016\/j.preteyeres.2025.101359_bib211","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1172\/JCI85193","article-title":"Reprogramming M\u00fcller glia via in vivo cell fusion regenerates murine photoreceptors","volume":"126","author":"Sanges","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.preteyeres.2025.101359_bib212","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/08830738040190091401","article-title":"Mouse models of tuberous sclerosis complex","volume":"19","author":"Scheidenhelm","year":"2004","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib213","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/332268a0","article-title":"Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma","volume":"332","author":"Seizinger","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2025.101359_bib214","series-title":"Handbook of Animal Models and its Uses in Cancer Research","first-page":"1","article-title":"Tumor models of retinoblastoma: in vivo, ex vivo, and in vitro models","author":"Sen","year":"2022"},{"key":"10.1016\/j.preteyeres.2025.101359_bib215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1086\/302726","article-title":"Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents","volume":"66","author":"Sgambati","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib216","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib217","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.ophtha.2017.04.003","article-title":"Personalized prognosis of uveal melanoma based on cytogenetic profile in 1059 patients over an 8-year period: the 2017 harry S. Gradle lecture","volume":"124","author":"Shields","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101359_bib218","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/modpathol.2011.61","article-title":"Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease","volume":"24","author":"Shively","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib219","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/NEN.0b013e3182032d37","article-title":"Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth","volume":"70","author":"Simmons","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib220","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/dbio.1999.9236","article-title":"Distinct 5' SCL enhancers direct transcription to developing brain, spinal cord, and endothelium: neural expression is mediated by GATA factor binding sites","volume":"209","author":"Sinclair","year":"1999","journal-title":"Dev. Biol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib221","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101359_bib222","series-title":"Clinical Ophthalmic Oncology: Uveal Tumors","first-page":"53","article-title":"Uveal melanoma: epidemiologic aspects","author":"Singh","year":"2019"},{"key":"10.1016\/j.preteyeres.2025.101359_bib223","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ajo.2020.12.005","article-title":"Uveal melanoma in BAP1 tumor predisposition syndrome: estimation of risk","volume":"224","author":"Singh","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib224","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcjo.2014.07.007","article-title":"Intravitreal bevacizumab for retinal capillary hemangioblastoma: a case series and literature review","volume":"49","author":"Slim","year":"2014","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib225","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neo.2015.10.002","article-title":"RNA sequencing of tumor-associated microglia reveals Ccl5 as a stromal chemokine critical for neurofibromatosis-1 glioma growth","volume":"17","author":"Solga","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.preteyeres.2025.101359_bib226","doi-asserted-by":"crossref","first-page":"47206","DOI":"10.18632\/oncotarget.17589","article-title":"The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation","volume":"8","author":"Solga","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.preteyeres.2025.101359_bib227","first-page":"622","article-title":"Human vestibular schwannoma growth in the nude mouse: evaluation of a modified subcutaneous implantation model","volume":"18","author":"Stidham","year":"1997","journal-title":"Am. J. Otol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib228","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","article-title":"Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene","volume":"12","author":"Stolle","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2025.101359_bib229","article-title":"Clinical development and management of adverse events associated with FGFR inhibitors","volume":"4","author":"Subbiah","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib230","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1242\/jcs.00094","article-title":"Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation","volume":"115","author":"Sun","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib231","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12134538","article-title":"Potential role of VHL, PTEN, and BAP1 mutations in renal tumors","volume":"12","author":"Szegedi","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib232","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/CMAR.S362678","article-title":"Neurofibromatosis type 1-associated optic pathway gliomas: current challenges and future prospects","volume":"15","author":"Tang","year":"2023","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib233","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib234","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/archopht.123.8.1088","article-title":"Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a\/Arf-\/- mice","volume":"123","author":"Tolleson","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib235","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/hmg\/ddw039","article-title":"NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1","volume":"25","author":"Toonen","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib236","first-page":"808","article-title":"Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction","volume":"19","author":"Toonen","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib237","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1084\/jem.20160447","article-title":"Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology","volume":"214","author":"Toonen","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib238","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.63.4.6","article-title":"Function of the retinal pigment epithelium in patients with neurofibromatosis type 1","volume":"63","author":"Touz\u00e9","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib239","doi-asserted-by":"crossref","DOI":"10.21037\/aes-21-30","article-title":"Animal models of uveal melanoma","volume":"7","author":"Uner","year":"2022","journal-title":"Ann. Eye Sci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib240","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib241","article-title":"Uveal melanoma modeling in mice and zebrafish","volume":"1879","author":"van den Bosch","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.preteyeres.2025.101359_bib242","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0306-4522(03)00571-2","article-title":"Expression pattern of the stem cell leukaemia gene in the CNS of the embryonic and adult mouse","volume":"122","author":"van Eekelen","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.preteyeres.2025.101359_bib243","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2025.101359_bib244","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.molcel.2012.10.018","article-title":"A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing mitogenic signals initiated by G protein-coupled receptors","volume":"49","author":"Vaqu\u00e9","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.preteyeres.2025.101359_bib245","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","article-title":"BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization","volume":"68","author":"Ventii","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib246","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10472","article-title":"Transplanted neurons integrate into adult retinas and respond to light","volume":"7","author":"Venugopalan","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101359_bib247","series-title":"Human Brain and Spinal Cord Tumors: from Bench to Bedside. Volume 2: the Path to Bedside Management","first-page":"377","article-title":"Hemangioblastomas and other vascular origating tumors of brain or spinal cord","author":"Vetrano","year":"2023"},{"key":"10.1016\/j.preteyeres.2025.101359_bib249","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jnci\/djad248","article-title":"Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants","volume":"116","author":"Villy","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.preteyeres.2025.101359_bib250","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1038\/sj.onc.1205575","article-title":"Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells","volume":"21","author":"Vooijs","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.preteyeres.2025.101359_bib251","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0046-8177(97)90075-7","article-title":"von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease","volume":"28","author":"Vortmeyer","year":"1997","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib252","series-title":"Abstract 1343: Preclinical Evaluation of a PKC and MET Inhibitor Combination in Metastatic Uveal Melanoma","author":"Wagle","year":"2021"},{"key":"10.1016\/j.preteyeres.2025.101359_bib253","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101359_bib254","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1158\/0008-5472.CAN-17-1718","article-title":"Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2025.101359_bib255","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaophthalmol.2016.0090","article-title":"Subretinal fluid associated with MEK inhibitor use in the treatment of systemic cancer","volume":"134","author":"Weber","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib256","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/302037","article-title":"An Analysis of Phenotypic Variation in the Familial Cancer Syndrome von Hippel\u2013Lindau Disease: Evidence for Modifier Effects","volume":"63","author":"Webster","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib257","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archopht.117.3.371","article-title":"Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation","volume":"117","author":"Webster","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib258","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2025.101359_bib259","doi-asserted-by":"crossref","DOI":"10.1038\/srep30742","article-title":"cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness","volume":"6","author":"Wiley","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101359_bib260","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1097\/IAE.0000000000002572","article-title":"Management of retinal hemangioblastoma IN VON hippel-lindau disease","volume":"39","author":"Wiley","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101359_bib261","first-page":"32","article-title":"Oral HIF-2\u03b1 inhibitor belzutifan for ocular von Hippel-Lindau (VHL) disease","volume":"62","author":"Wiley","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.preteyeres.2025.101359_bib262","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.ophtha.2024.05.024","article-title":"Oral Hypoxia-Inducible Factor 2\u03b1 Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study","volume":"131","author":"Wiley","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101359_bib263","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.jaad.2020.07.105","article-title":"Neurofibromatosis type 1: new developments in genetics and treatment","volume":"84","author":"Wilson","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib264","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archopht.125.2.239","article-title":"Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis","volume":"125","author":"Wong","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib265","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ophtha.2007.03.009","article-title":"Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101359_bib266","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063088","article-title":"Microglia development and maturation and its implications for induction of microglia-like cells from human iPSCs","volume":"22","author":"Wurm","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101359_bib267","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101359_bib268","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccr.2014.04.017","article-title":"Mutant Gq\/11 promote uveal melanoma tumorigenesis by activating YAP","volume":"25","author":"Yu","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.preteyeres.2025.101359_bib269","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","article-title":"Germline mutations in the von hippel-lindau disease (VHL) gene in families from north America, europe, and Japan","volume":"8","author":"Zbar","year":"1996","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2025.101359_bib270","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6010035","article-title":"VHL and hypoxia signaling: beyond HIF in cancer","volume":"6","author":"Zhang","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.preteyeres.2025.101359_bib271","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4161\/cc.3.7.1002","article-title":"The first knockout mouse model of retinoblastoma","volume":"3","author":"Zhang","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.preteyeres.2025.101359_bib272","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/path.5908","article-title":"Novel patient-derived xenograft and cell line models for therapeutic screening in NF2-associated schwannoma","volume":"257","author":"Zhao","year":"2022","journal-title":"J. Pathol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib273","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41581-022-00544-5","article-title":"Belzutifan: a novel therapy for von Hippel-Lindau disease","volume":"18","author":"Zhou","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.preteyeres.2025.101359_bib274","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1242\/dev.02162","article-title":"Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation","volume":"132","author":"Zhu","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.preteyeres.2025.101359_bib275","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature07589","article-title":"Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation","volume":"457","author":"Zhu","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2025.101359_bib276","series-title":"Clinical Ophthalmic Oncology: Uveal Tumors","first-page":"71","article-title":"Uveal melanoma: clinical features","author":"Zografos","year":"2019"}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946225000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946225000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:04:01Z","timestamp":1764043441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946225000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":271,"alternative-id":["S1350946225000321"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101359","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics and current research models of Mendelian tumor predisposition syndromes with ocular involvement","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101359"}}